Pricing Log in Create free account

Lisata Therapeutics, Inc. (LSTA) vs Tvardi Therapeutics, Inc. (TVRD)

Lisata Therapeutics, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Lisata Therapeutics, Inc. and Tvardi Therapeutics, Inc. are of similar size ($11.5M and $10.7M). Lisata Therapeutics, Inc. grew revenue faster over the last twelve months: −24.7% against −55.3%. Across the 13 metrics below, Lisata Therapeutics, Inc. leads on 9 and Tvardi Therapeutics, Inc. on 4.

Valuation

Metric LSTA TVRD Biotechnology median
P/E n/m n/m 10.26
P/S 0.60 1.05 9.18
P/B 1.15 0.95 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 0.13 6.83 8.98
Earnings yield (162.38%) (328.24%) (34.89%)
Free cash flow yield (134.29%) (353.24%) (24.52%)

Profitability

Metric LSTA TVRD Biotechnology median
Gross margin 0.49% 146.85% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.66%) (126.19%) (50.12%)
Return on assets (80.81%) (85.08%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSTA TVRD Biotechnology median
Revenue growth (TTM) (24.67%) (55.30%) 6.26%
EPS growth (last fiscal year) 20.42% 71.45% 29.88%
Revenue growth, 5-year CAGR (20.28%) (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LSTA TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.69 1.87 4.89
Net debt to EBITDA 0.88 1.15 1.01

Dividend

Metric LSTA TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LSTA TVRD Biotechnology median
Market cap 10.71m 11.53m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack